From the Department of Radiology (D.S.B.)
Center for Functional Magnetic Resonance Imaging (D.S.B.), UC San Diego, La Jolla, California.
AJNR Am J Neuroradiol. 2019 Nov;40(11):1842-1849. doi: 10.3174/ajnr.A6262. Epub 2019 Nov 6.
Imaging CBF is important for managing pediatric moyamoya. Traditional arterial spin-labeling MR imaging detects delayed transit thorough diseased arteries but is inaccurate for measuring perfusion because of these delays. Velocity-selective arterial spin-labeling is insensitive to transit delay and well-suited for imaging Moyamoya perfusion. This study assesses the accuracy of a combined velocity-selective arterial spin-labeling and traditional pulsed arterial spin-labeling CBF approach in pediatric moyamoya, with comparison to blood flow patterns on conventional angiography.
Twenty-two neurologically stable pediatric patients with moyamoya and 5 asymptomatic siblings without frank moyamoya were imaged with velocity-selective arterial spin-labeling, pulsed arterial spin-labeling, and DSA (patients). Qualitative comparison was performed, followed by a systematic comparison using ASPECTS-based scoring. Quantitative pulsed arterial spin-labeling CBF and velocity-selective arterial spin-labeling CBF for the middle cerebral artery, anterior cerebral artery, and posterior cerebral artery territories were also compared.
Qualitatively, velocity-selective arterial spin-labeling perfusion maps reflect the DSA parenchymal phase, regardless of postinjection timing. Conversely, pulsed arterial spin-labeling maps reflect the DSA appearance at postinjection times closer to the arterial spin-labeling postlabeling delay, regardless of vascular phase. ASPECTS comparison showed excellent agreement (88%, κ = 0.77, < .001) between arterial spin-labeling and DSA, suggesting velocity-selective arterial spin-labeling and pulsed arterial spin-labeling capture key perfusion and transit delay information, respectively. CBF coefficient of variation, a marker of perfusion variability, was similar for velocity-selective arterial spin-labeling in patient regions of delayed-but-preserved perfusion compared to healthy asymptomatic sibling regions (coefficient of variation = 0.30 versus 0.26, respectively, Δcoefficient of variation = 0.04), but it was significantly different for pulsed arterial spin-labeling (coefficient of variation = 0.64 versus 0.34, Δcoefficient of variation = 0.30, < .001).
Velocity-selective arterial spin-labeling offers a powerful approach to image perfusion in pediatric moyamoya due to transit delay insensitivity. Coupled with pulsed arterial spin-labeling for transit delay information, a volumetric MR imaging approach capturing key DSA information is introduced.
成像 CBF 对于管理儿科 moyamoya 非常重要。传统的动脉自旋标记 MR 成像可以检测到通过病变动脉的延迟通过,但由于这些延迟,其测量灌注的准确性较差。速度选择性动脉自旋标记对通过延迟不敏感,非常适合成像 moyamoya 灌注。本研究通过与常规血管造影的血流模式进行比较,评估了一种组合的速度选择性动脉自旋标记和传统脉冲动脉自旋标记 CBF 方法在儿科 moyamoya 中的准确性。
22 例神经稳定的 moyamoya 患儿和 5 例无明显 moyamoya 的无症状兄弟姐妹进行了速度选择性动脉自旋标记、脉冲动脉自旋标记和 DSA(患者)成像。进行了定性比较,然后使用 ASPECTS 评分进行了系统比较。还比较了大脑中动脉、大脑前动脉和大脑后动脉区域的定量脉冲动脉自旋标记 CBF 和速度选择性动脉自旋标记 CBF。
定性上,速度选择性动脉自旋标记灌注图反映了 DSA 实质期,而与注射后时间无关。相反,脉冲动脉自旋标记图反映了在更接近动脉自旋标记后标记延迟的注射后时间的 DSA 外观,而与血管期无关。ASPECTS 比较表明,动脉自旋标记和 DSA 之间具有极好的一致性(88%,κ=0.77, <.001),表明速度选择性动脉自旋标记和脉冲动脉自旋标记分别捕获了关键的灌注和通过延迟信息。CBF 变异系数是灌注变异性的一个标志物,在延迟但保留灌注的患者区域的速度选择性动脉自旋标记中与健康无症状兄弟姐妹区域相似(变异系数分别为 0.30 和 0.26,Δ变异系数为 0.04),但在脉冲动脉自旋标记中差异显著(变异系数分别为 0.64 和 0.34,Δ变异系数为 0.30, <.001)。
速度选择性动脉自旋标记由于通过延迟不敏感,为儿科 moyamoya 成像提供了一种强大的灌注方法。结合用于通过延迟信息的脉冲动脉自旋标记,引入了一种捕获关键 DSA 信息的容积磁共振成像方法。